Literature DB >> 23011045

[Near-infrared spectroscopy in sepsis therapy : predictor of a low central venous oxygen saturation].

C Lichtenstern1, C Koch, R Röhrig, B Rosengarten, M Henrich, M A Weigand.   

Abstract

BACKGROUND: Early goal-directed hemodynamic optimization has become a cornerstone of sepsis therapy. One major defined goal is to achieve adequate central venous oxygen saturation (SO(2)). This study aimed to investigate the correlation between central venous SO(2) and frontal cerebral near-infrared spectroscopy (NIRS) measurement in patients with severe sepsis and septic shock. The NIRS method provides non-invasive measurement of regional oxygen saturation (rSO(2)) in tissues approximately 2 cm below the optical NIRS sensors which depends on arterial, capillary and venous blood. Thus this system gives site-specific real-time data about the balance of oxygen supply and demand.
METHODS: This was a secondary analysis from a prospective study of surgical intensive care (ICU) patients in the early phase of severe sepsis or septic shock. Bilateral cerebral rSO(2), central venous SO(2), arterial oxygen saturation (S(a)O(2)) and other surrogate parameters of oxygen supply, such as hemoglobin, partial pressure of oxygen and oxygen content in arterial blood were recorded.
RESULTS: A total of 16 ICU patients (4 women, median age 65.5 years) were included in the study. As sepsis focus an intra-abdominal infection was detected in 62.5 % of patients, severe pneumonia was determined in 31.3 % and skin and soft tissue infections were recognized in 12.5 %. At study inclusion 50 % of patients had septic shock, the median sequential organ failure assessment (SOFA) score was 10.2 (interquartile range 5.25-8.75) and the median acute physiology and chronic health evaluation II (APACHE II) score was 26 (range 23.25-29.75). Mortality at day 28 was 37.5 %. Minimum rSO(2) (median 58) and right-sided rSO(2) (median 58) values showed a significant correlation in the analysis of receiver operating characteristics (area under the curve 0.844, p= 0.045). A central venous SO(2)< 70 % was indicated by rSO(2)< 56.5 with sensitivity and specificity of 75 % and 100 %, respectively.
CONCLUSIONS: Cerebral NIRS could provide a fast and easily available side effect-free monitoring that could be used in addition to established procedures for goal-directed treatment in the early phase of sepsis. Further studies should be made in a larger population to verify the correlation found and to investigate the impact of NIRS-directed resuscitation treatment in early sepsis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23011045     DOI: 10.1007/s00101-012-2087-0

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  35 in total

1.  Non-invasive cerebral oxygenation reflects mixed venous oxygen saturation during the varying haemodynamic conditions in patients undergoing transapical transcatheter aortic valve implantation.

Authors:  Hauke Paarmann; Matthias Heringlake; Hermann Heinze; Thorsten Hanke; Holger Sier; Jan Karsten; Julika Schön
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-12-07

Review 2.  Continuous central venous oximetry monitoring.

Authors:  Cindy Goodrich
Journal:  Crit Care Nurs Clin North Am       Date:  2006-06       Impact factor: 1.326

Review 3.  Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications.

Authors:  Martin Wolf; Marco Ferrari; Valentina Quaresima
Journal:  J Biomed Opt       Date:  2007 Nov-Dec       Impact factor: 3.170

4.  Role of central and mixed venous oxygen saturation measurement in perioperative care.

Authors:  Stephen J Shepherd; Rupert M Pearse
Journal:  Anesthesiology       Date:  2009-09       Impact factor: 7.892

5.  Optimizing intraoperative cerebral oxygen delivery using noninvasive cerebral oximetry decreases the incidence of stroke for cardiac surgical patients.

Authors:  Scott Goldman; Francis Sutter; Francis Ferdinand; Candace Trace
Journal:  Heart Surg Forum       Date:  2004       Impact factor: 0.676

Review 6.  The value of near-infrared spectroscopy measured cerebral oximetry during carotid endarterectomy in perioperative stroke prevention. A review.

Authors:  C W A Pennekamp; M L Bots; L J Kappelle; F L Moll; G J de Borst
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-08-07       Impact factor: 7.069

7.  Masseter tissue oxygen saturation predicts normal central venous oxygen saturation during early goal-directed therapy and predicts mortality in patients with severe sepsis.

Authors:  Gwenhael Colin; Olivier Nardi; Andrea Polito; Jérôme Aboab; Virginie Maxime; Bernard Clair; Diane Friedman; David Orlikowski; Tarek Sharshar; Djillali Annane
Journal:  Crit Care Med       Date:  2012-02       Impact factor: 7.598

8.  Thenar oxygen saturation measured by near infrared spectroscopy as a noninvasive predictor of low central venous oxygen saturation in septic patients.

Authors:  Jaume Mesquida; Jordi Masip; Gisela Gili; Antoni Artigas; Francisco Baigorri
Journal:  Intensive Care Med       Date:  2009-01-29       Impact factor: 17.440

9.  Optimizing hemodynamic support in septic shock using central and mixed venous oxygen saturation.

Authors:  Supriya Maddirala; Akram Khan
Journal:  Crit Care Clin       Date:  2010-04       Impact factor: 3.879

10.  Cerebral and somatic venous oximetry in adults and infants.

Authors:  Erin A Booth; Chris Dukatz; James Ausman; Michael Wider
Journal:  Surg Neurol Int       Date:  2010-11-27
View more
  2 in total

Review 1.  In vivo validation of cerebral near-infrared spectroscopy: a review.

Authors:  Amalie la Cour; Gorm Greisen; Simon Hyttel-Sorensen
Journal:  Neurophotonics       Date:  2018-11-27       Impact factor: 3.593

2.  Prospective evaluation of regional oxygen saturation to estimate central venous saturation in sepsis.

Authors:  Christian Koch; Rainer Röhrig; Tobias Monz; Andreas Hecker; Florian Uhle; Emanuel Schneck; Markus A Weigand; Christoph Lichtenstern
Journal:  J Clin Monit Comput       Date:  2015-03-11       Impact factor: 2.502

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.